New Guide on Successfully Using RWE in Drug Development Pipeline

Using real world evidence (RWE) continues to be a valuable alternative to the traditional clinical trial. A new guide from United BioSource (UBC) provides insight into how to utilize RWE, generate RWE from patient registries, and understand the post-market space with RWE tools.

“How do you successfully use existing registries to generate impactful evidence? This article breaks down the three key ingredients to the successful creation of evidence generation strategies. Regulatory agencies, payers, and the scientific community are all encouraging: pharma sponsors to implement strategies that leverage established registry data to support real-world evidence (RWE) generation for new and established treatments.” Read more here.

(Source: UBC, 2021)